Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and partner Sandoz have created a generic version of the drug which is awaiting approval from the U.S. Food and Drug Administration. Drug company Mylan also has plans to market a generic version of the drug.Momenta (Nasdaq: MNTA) CFO Rick Shea said in an interview today that the other eight patents all expire on May 24. He said the FDA could approve Momenta and Sondoz’s generic drug anytime after that, over Teva’s objections, but the agency has no set deadline when it must do so. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) stock performance was 10.98% in last session and finished the day at $11.93. Traded volume was 1,595,721 shares in the last session and the average volume of the stock remained 990.32K shares. The beta of the stock remained 1.58. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider ownership is 2.50%.
Home health and hospice services provider Gentiva Health Services, Inc.’s (GTIV) board on Thursday rejected a unsolicited, non-binding $533 million cash and stock acquisition offer from healthcare services provider Healthcare, Inc. (NYSE:KND), saying the offer undervalues the company.Earlier in the day, Kindred Healthcare proposed to acquire Gentiva for $14 per share in a cash and stock deal valued at about $533 million. The consideration includes $7.00 per share in cash and $7.00 of Kindred common stock. The deal would be valued at about $1.6 billion, including assumed debt. Kindred Healthcare, Inc. (NYSE:KND) rose 10.95% to $24.32 yesterday on volume of 1,773,095 shares. The intra-day range of the stock was $21.94 – 24.37. Kindred Healthcare, Inc. (NYSE:KND) has a market capitalization of $1.32 billion.
The most recent short interest data has been released by the NASDAQ for the 04/30/2014 settlement date, which shows a 757,364 share increase in total short interest for Ur-Energy Inc. (USA) (NYSEMKT:URG), to 7,278,643, an increase of 11.61% since 04/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the “days to cover” metric because it considers both the total shares short and the average daily volume of shares traded. Ur-Energy Inc. (USA) (NYSEMKT:URG)’s stock on May 15, 2014 reported an increase 9.90% to the closing price of $1.11. Its fifty two weeks range is $0.84 – 1.99. The total market capitalization recorded $ 142.90 million. The overall volume in the last trading session was 1,775,470 shares. In its share capital, Ur-Energy Inc. (USA) (NYSEMKT:URG) has 130.70 million outstanding shares.
Bonanza Creek Energy Inc (NASDAQ:BCEI) last released its earnings data on Thursday, May 8th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.53 by $0.07. The company had revenue of $127.40 million for the quarter, compared to the consensus estimate of $124.05 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was up 62.7% on a year-over-year basis. Analysts expect that Bonanza Creek Energy will post $2.74 EPS for the current fiscal year. On Thursday, shares of Bonanza Creek Energy Inc (NYSE:BCEI) advanced 5.26% to close the day at $44.83. Company return on investment (ROI) is 8.90% and its monthly performance is recorded as -7.20%. Bonanza Creek Energy Inc (NYSE:BCEI) quarterly revenue growth is 0.76%.
Security and defense products provider, Arotech Corporation (NASDAQ:ARTX) announced 62.3% jump in profit for the first quarter driven by strong expansion of gross margin, as the revenue growth was a slender 1.4% over the last year quarter.Arotech Corporation (NASDAQ:ARTX) said that its revenue rose a meager 1.4% to $22.4 million from $22.1 million in the previous year quarter. A Wall Street analyst predicted the company to generate revenue of $22.38 million. Arotech Corporation (NASDAQ:ARTX) stock performance was 7.48% in last session and finished the day at $4.31. Traded volume was 1,870,916 shares in the last session and the average volume of the stock remained 1.93 million shares. The beta of the stock remained 0.56. Arotech Corporation (NASDAQ:ARTX) insider ownership is 15.60%.